Connection

Search Results to Lillian E.C. McMahon, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of McMahon, Lillian

PropertyValue
Research Expertise & Professional Interests Expertise includes: Sickle cell anemia; Sickle cell disease; Hemoglobin C disease; Hemoglobinopathies.
Self-Described Keywords Sickle cell disease
Self-Described Keywords Hemoglobin C disease
Self-Described Keywords Sickle cell anemia

One or more keywords matched the following items that are connected to McMahon, Lillian

Item TypeName
Concept Anemia, Sickle Cell
Academic Article Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.
Academic Article Health-related quality of life in children with sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium.
Academic Article A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers.
Academic Article Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE).
Academic Article A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.
Grant Controlled Study to Determine the Effects of Procrit kEpoetin Alfa in Patients with Sickle Cell Anemia Who are Receiving Hydroxyurea
Grant A Phase II, Multicenter, Twelve-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Efficacy and Safety of ICA-17043 with or without Hydorxyurea Therapy in Patients with Sickle Cell Anemia
Grant Vertex Human Tissue Request: Sickle Cell Disease (SCD)
Grant A 5-year, prospective, non-interventional, multi-center registry in Sickle Cell Disease patients
Grant A Phase ll, Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SeIG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Si
Grant A Phase III, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle B0- Thalassemia
Grant Blood Samples, Blood Laboratory Test Results and Questionnaire Data from Sickle Cell Disease Blood Donors Collected under an IRB Approved Protocol with Signed Informed Consent
Grant Protocol # STERIO-SCD, A Phase lib Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients with Sickle Cell Diseases
Grant A Double-Blind, Randomized, Multicenter Study of Prasugrel Compared to Placebo in Adult Patients with Sickle Cell Disease
Grant Neutrophil Elastase as a Biomarker for Neutrophil-mediated Pathbiology in Sickle Cell Disease
Grant Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease

Highlights
Search Criteria
  • sickle cell disease